Already on the strength of its vaccine success, the American pharmaceutical giant Pfizer is pursuing its quest for a drug against Covid-19 in parallel.
To discover
Covid-19: instructions for use of self-tests
Read also:
Covid-19: the trail of a laboratory leak resurfaces
Designated by an encrypted code (PF-07321332), this treatment is in the form of a tablet to be swallowed at the first symptoms.
If the active ingredient has proven its effectiveness on the virus grown in the laboratory (as well as on other coronaviruses), phase 1 trials have just started in humans in March.
About sixty volunteers were recruited to verify the safety of the treatment at different dosages.
An essential preliminary step to continue clinical trials which will then aim to demonstrate its therapeutic value.
A type of treatment already successful
While there is still a long way to go, the molecule is already considered very promising by specialists.
"Unlike most of the drugs tested to date, this treatment has been specifically developed against Sars-CoV-2"
, emphasizes Christophe Bécavin, teacher-researcher
This article is for subscribers only.
You have 82% left to discover.
Subscribe: 1 € the first month
Can be canceled at any time
I ENJOY IT
Already subscribed?
Log in